Periodontal Assessment in RA Study (PARAS)
RA 研究中的牙周评估 (PARAS)
基本信息
- 批准号:7033758
- 负责人:
- 金额:$ 8.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-07-01 至 2008-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The pathogenic mechanisms of rheumatoid arthritis (RA) and periodontal disease (PD) are remarkably similar, with similar cellular events in the inflammatory focus, common profiles of cytokines, proteases, and inflammatory markers, and bone and collagen degradation. An increased prevalence of PD has been described in patients with longstanding RA, yet further exploration of this association has been limited. Many have argued that RA predisposed to the development of PD with hypothesized interactions of decreased salivary pool, poor oral hygiene from hand disability, or medication effects. The growing appreciation of Anti-CCP antibodies as diagnostic and prognostic markers for RA is significant, given that certain strains of bacteria associated with progressive periodontal disease represent a source of an enzyme producing citrullinated peptides, potentially serving to trigger the attendant antibody response seen in RA. Thus, it is possible that PD serves as a precipitant for some cases of RA or is a modifying factor of the disease. The recognition of an influence of PD on other systemic illnesses, notably diabetes and atherosclerotic disease, in which shared pathogenic mechanisms are less clear, provide additional rationale to evaluate relationships between PD and RA, diseases in which the mechanisms of disease have many similarities.
It is our hypothesis that the prevalence of periodontal disease in RA patients at the onset of their arthritic disease is increased compared to matched controls without RA and that the presence and severity of PD will correlate with RA disease activity.
Specific Aim 1 is to evaluate a cohort of subjects with newly diagnosed RA for periodontal health compared
to control subjects without arthritis. The primary outcome measurement will be the presence of periodontal
disease in RA compared to non-arthritic controls.
Specific Aim 2 is to explore relationships between RA disease activity with periodontal severity. These studies represent the first comprehensive evaluation of periodontal disease in early RA and will provide important preliminary data and biological samples for further studies of disease progression, response to therapy, and to elucidate common mechanisms of pathogenesis. This study represents a collaborative effort between Rheumatology at Johns Hopkins, the Univ. Of Maryland College of Dental Surgery, and NYU College of Dentistry. The relationships developed for this study constitute a unique multi-centered interdisciplinary group of investigators and will facilitate the preparation and implementation of much broader research proposals to more clearly define the overall oral health of patients with RA.
描述(由申请人提供):类风湿关节炎(RA)和牙周病(PD)的致病机制非常相似,炎症灶中有相似的细胞事件,细胞因子、蛋白酶和炎症标志物的共同特征,以及骨和胶原降解。长期类风湿关节炎患者PD患病率增加,但对这种关联的进一步探索受到限制。许多人认为,类风湿性关节炎易患帕金森病,与假设的唾液池减少、手部残疾导致的口腔卫生不良或药物作用相互作用。鉴于某些与进进性牙周病相关的细菌菌株是产生瓜氨酸化肽的酶的来源,可能有助于引发RA中所见的伴随抗体反应,抗ccp抗体作为RA的诊断和预后标记物的价值日益增加。因此,PD可能是某些RA病例的诱发因素,或者是该疾病的修饰因素。认识到帕金森病对其他全身性疾病的影响,特别是糖尿病和动脉粥样硬化性疾病,其中共同的致病机制尚不清楚,为评估帕金森病和RA之间的关系提供了额外的依据,这些疾病的发病机制有许多相似之处。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CLIFTON O BINGHAM其他文献
CLIFTON O BINGHAM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CLIFTON O BINGHAM', 18)}}的其他基金
Johns Hopkins Rheumatic Diseases Resource-based Core Center (Johns Hopkins RDRCC)
约翰霍普金斯风湿病资源核心中心(约翰霍普金斯 RDRCC)
- 批准号:
10487438 - 财政年份:2016
- 资助金额:
$ 8.18万 - 项目类别:
Johns Hopkins Rheumatic Diseases Resource-based Core Center
约翰·霍普金斯风湿病资源核心中心
- 批准号:
9752316 - 财政年份:2016
- 资助金额:
$ 8.18万 - 项目类别:
Johns Hopkins Rheumatic Diseases Resource-based Core Center
约翰·霍普金斯风湿病资源核心中心
- 批准号:
9162939 - 财政年份:2016
- 资助金额:
$ 8.18万 - 项目类别:
Johns Hopkins Rheumatic Diseases Resource-based Core Center (Johns Hopkins RDRCC)
约翰霍普金斯风湿病资源核心中心(约翰霍普金斯 RDRCC)
- 批准号:
10281309 - 财政年份:2016
- 资助金额:
$ 8.18万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
对类风湿性关节炎关联基因PADI4病理途径的系统性研究
- 批准号:30972720
- 批准年份:2009
- 资助金额:30.0 万元
- 项目类别:面上项目
CXCL16/CXCR6调控CIA发病的分子机制研究
- 批准号:30772012
- 批准年份:2007
- 资助金额:35.0 万元
- 项目类别:面上项目
相似海外基金
The natural release of unusual peptidoglycan fragments drives persistent Lyme disease symptoms in susceptible hosts
异常肽聚糖片段的自然释放导致易感宿主持续出现莱姆病症状
- 批准号:
10736544 - 财政年份:2023
- 资助金额:
$ 8.18万 - 项目类别:
Novel immune-escape uricase for treatment of hyperuricemia
治疗高尿酸血症的新型免疫逃逸尿酸酶
- 批准号:
10696609 - 财政年份:2023
- 资助金额:
$ 8.18万 - 项目类别:
A Novel Mucosal Vaccine for Pseudomonas aeruginosa Infection
一种针对铜绿假单胞菌感染的新型粘膜疫苗
- 批准号:
10446501 - 财政年份:2022
- 资助金额:
$ 8.18万 - 项目类别:
Pathogenicity of the emerging pathogen Kingella kingae
新出现的病原体金氏菌的致病性
- 批准号:
10559927 - 财政年份:2022
- 资助金额:
$ 8.18万 - 项目类别:
Gut Immunity, Neurovascular Dysregulation and Cognitive Impairment
肠道免疫、神经血管失调和认知障碍
- 批准号:
10706330 - 财政年份:2022
- 资助金额:
$ 8.18万 - 项目类别:
A Novel Mucosal Vaccine for Pseudomonas aeruginosa Infection
一种针对铜绿假单胞菌感染的新型粘膜疫苗
- 批准号:
10550157 - 财政年份:2022
- 资助金额:
$ 8.18万 - 项目类别:
Investigating Mucosal Breaks in the Initiation and Progression of Rheumatoid Arthritis
研究类风湿关节炎发生和进展过程中的粘膜破裂
- 批准号:
10436924 - 财政年份:2021
- 资助金额:
$ 8.18万 - 项目类别:
Detecting released peptidoglycan fragments as a biomarker for direct diagnosis of acute and chronic Lyme disease
检测释放的肽聚糖片段作为直接诊断急性和慢性莱姆病的生物标志物
- 批准号:
10369673 - 财政年份:2021
- 资助金额:
$ 8.18万 - 项目类别:
Investigating Mucosal Breaks in the Initiation and Progression of Rheumatoid Arthritis
研究类风湿关节炎发生和进展过程中的粘膜破裂
- 批准号:
10615760 - 财政年份:2021
- 资助金额:
$ 8.18万 - 项目类别:
Detecting released peptidoglycan fragments as a biomarker for direct diagnosis of acute and chronic Lyme disease
检测释放的肽聚糖片段作为直接诊断急性和慢性莱姆病的生物标志物
- 批准号:
10195072 - 财政年份:2021
- 资助金额:
$ 8.18万 - 项目类别:














{{item.name}}会员




